BSE · KABRADG
Kabra Drugs Ltd (KABRADG) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,544
of 5,047 stocks
▲ 871W▲ 591M
Peak #3,482 · 02 Oct 2026
A microcap name in Healthcare, Kabra Drugs Ltd trades at an undemanding earnings multiple, has a widely-held ownership base, with promoters at just 0%, and is growing revenue modestly.
Market Cap
45.07 Cr
P/E Ratio
9.10
P/B Ratio
1.52
ROE
16.75%
ROCE
19.34%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 31.95 Cr | 46.22 Cr | 35.41 Cr | 30.42 Cr |
| Net Profit | 1.92 Cr | 2.12 Cr | 1.06 Cr | 2.57 Cr |
| EPS | 0.81 | 0.90 | 0.45 | 1.08 |
| Operating Profit | 2.67 Cr | 2.85 Cr | 1.44 Cr | 2.60 Cr |
Shareholding pattern
Promoter
0.00%
Public
100.00%
PUBLIC BREAKDOWN
Individuals
93.10%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 13 Sep 2006 | Other | General |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.